IS IT ethical to administer an experimental COVID-19 vaccine to a healthy person and then infect him/her with the novel coronavirus to check if the vaccine has immunised the individual against the pathogen? The question is at the centre of a global debate ever since the UK allowed a study, called human challenge trial (HCT), on a COVID-19 vaccine which will be conducted in January 2021.
Normally, a vaccine goes through three phases of human trials. The first phase tests for safety, the second immunogenicity (ability to trigger immune response) and the third involves large-scale testing on tens of thousands of participants of varied populations, who are injected with the vaccine and observed over a long period, even years, for efficacy. In HCT, instead of the third phase trial, a small number of healthy participants (often less than 100) are recruited, at times for money, and administered the vaccine before being injected with a less virulent strain of the virus. HCT thus reduces the trial period by months. The danger, however, is that the injected virus may cause severe illness or even death of the participants during the study.
HCT is not a new concept. It was used for the development of anti-malarial and cholera vaccines in the 1970s. But when HCT was undertaken to develop vaccines for these diseases, drugs to treat them were already there. If a participant became ill, there was a cure available. This is not the case with COVID-19, because there is no guaranteed cure.
This story is from the October 16, 2020 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 16, 2020 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
A SPRIG TO CARE FOR
Punarnava, a perennial herb, is easy to grow and has huge health benefits
DIGGING A DISASTER
Soapstone mining near Dabti Vijaypur village has caused many residents to migrate.
REVIEW THE TREATMENT
Several faecal sludge treatment plants in Uttar Pradesh suffer from design flaws that make the treatment process both expensive and inefficient
MAKE STEEL SUSTAINABLE
As India works to double its GDP by 2030, its steel industry must balance growth with sustainability. By embracing policies like the Steel Scrap Recycling Policy 2019 and adopting green technologies, India is paving the way for a more sustainable future in steel production
Can ANRF pull off the impossible for India?
Anusandhan National Research Foundation is expected to reorient India's innovation goals but funding issues, old mindsets remain a drag
TROUBLED WOODS
Forests are a great bulwark against climate change. But this is fast changing. AKSHIT SANGOMLA travels through some of the pristine patches of the Western Ghats to explore how natural disturbances triggered by global warming now threaten the forest health
BLINDING GLOW
The science is clear: increased illumination has damaging consequences for the health of humans, animals and plants. It’s time governments introduced policies to protect the natural darkness and improved the quality of outdoor lighting.
GROUND REALITY
What happens when the soil loses the ability to grow healthy, high-yield crops on its own?
GM POLICY MUST BE FARMER CENTRIC
On July 23, the Supreme Court of India directed the Union government to develop a national policy on genetically modified (GM) crops for research, cultivation, trade and commerce through public consultation.
Vinchurni's Gandhi
A 96-year-old farmer transforms barren land into a thriving forest in drought-prone region of Satara